Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

Pfizer's (NYSE: PFE) shares have been southbound for the better part of three years, partly because it was unable to repeat its incredible financial performance during the ... Here's why the stock is ...

In the latest trading session, Pfizer (PFE) closed at $22.15, marking a +0.48% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other ...

PFE’s weak performance can be linked to declining demand ... Analysts’ consensus opinion on PFE stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 22 analysts ...

CNBC highlights this by examining the historical performance of the broader market. Between 1960 and 2024, a $10,000 investment in the index would have grown to over $982,000 purely from stock ...

We recently published a list of the 11 Best Dividend Paying Stocks According to Hedge Funds. In this article, we are going to ...

US stocks saw choppy trading on Tuesday (April 15) as investors digested a new round of first-quarter earnings reports and ...

We think Pfizer stock is worth $42 per share ... the Internet of Things, and high-performance computing applications, which may last decades. Taiwan Semiconductor stock trades 42% below our ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

The stock's fall snapped a three-day winning streak.